SA
FBRX logo
Forte Biosciences, Inc.(FBRX)
Closing price · checked 4:30 PM ETAbout this dataData status
$76.99▲0.00 (0.00%)
Extended:$77.00+0.01 (+0.01%)· 4:30 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Forte Biosciences, Inc. (FBRX)

Total Non-Current Assets

$2.64M

Quarterly · Period ending: · USD

FBRX logo

FBRX Total Non-Current Assets

Latest reported$2.19M
FBRX FY Non-Current Assets ($1.97M → $2.19M)
Powered by
High-resolution chart · PNG

What is total non-current assets?

Long-term assets expected to provide value beyond one year.

FBRX total non-current assets history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Forte Biosciences, Inc. Total Non-Current Assets — Annual fiscal periods (USD)
Period endingTotal Non-Current Assets (USD)Change
2,190,000+918.60%
215,000−67.08%
653,000+34.36%
486,000−38.17%
786,000−41.39%
1,341,000+782.24%
152,000−97.15%
5,333,000+269.32%
1,444,000−50.03%
2,890,000+46.70%
1,970,000—

Frequently asked questions: FBRX total non-current assets

What is Forte Biosciences, Inc. (FBRX)'s current total non-current assets?

Forte Biosciences, Inc. (FBRX)'s latest reported total non-current assets (Quarterly) is $2.64M as of Jun 30, 2026. Long-term assets expected to provide value beyond one year.

How much historical total non-current assets data is available for FBRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Forte Biosciences, Inc. (FBRX)'s total non-current assets, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare FBRX's total non-current assets to peers or set an alert?

You can open FBRX's total non-current assets in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on FBRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.